These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 31489174)

  • 1. Trim the fat: the role of omega-3 fatty acids in psychopharmacology.
    Nasir M; Bloch MH
    Ther Adv Psychopharmacol; 2019; 9():2045125319869791. PubMed ID: 31489174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.
    Sarris J; Ravindran A; Yatham LN; Marx W; Rucklidge JJ; McIntyre RS; Akhondzadeh S; Benedetti F; Caneo C; Cramer H; Cribb L; de Manincor M; Dean O; Deslandes AC; Freeman MP; Gangadhar B; Harvey BH; Kasper S; Lake J; Lopresti A; Lu L; Metri NJ; Mischoulon D; Ng CH; Nishi D; Rahimi R; Seedat S; Sinclair J; Su KP; Zhang ZJ; Berk M
    World J Biol Psychiatry; 2022 Jul; 23(6):424-455. PubMed ID: 35311615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.
    Freeman MP; Hibbeln JR; Wisner KL; Davis JM; Mischoulon D; Peet M; Keck PE; Marangell LB; Richardson AJ; Lake J; Stoll AL
    J Clin Psychiatry; 2006 Dec; 67(12):1954-67. PubMed ID: 17194275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.
    Kelaiditis CF; Gibson EL; Dyall SC
    Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102572. PubMed ID: 37028202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.
    Grosso G; Pajak A; Marventano S; Castellano S; Galvano F; Bucolo C; Drago F; Caraci F
    PLoS One; 2014; 9(5):e96905. PubMed ID: 24805797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis.
    Bloch MH; Hannestad J
    Mol Psychiatry; 2012 Dec; 17(12):1272-82. PubMed ID: 21931319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data.
    Bozzatello P; Brignolo E; De Grandi E; Bellino S
    J Clin Med; 2016 Jul; 5(8):. PubMed ID: 27472373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids for bipolar disorder.
    Montgomery P; Richardson AJ
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005169. PubMed ID: 18425912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of n-3 polyunsaturated fatty acids (n-3PUFAs) in affective disorders.
    Ciappolino V; Delvecchio G; Agostoni C; Mazzocchi A; Altamura AC; Brambilla P
    J Affect Disord; 2017 Dec; 224():32-47. PubMed ID: 28089169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acids and mood disorders.
    Parker G; Gibson NA; Brotchie H; Heruc G; Rees AM; Hadzi-Pavlovic D
    Am J Psychiatry; 2006 Jun; 163(6):969-78. PubMed ID: 16741195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.
    Newberry SJ; Chung M; Booth M; Maglione MA; Tang AM; O'Hanlon CE; Wang DD; Okunogbe A; Huang C; Motala A; Trimmer M; Dudley W; Shanman R; Coker TR; Shekelle PG
    Evid Rep Technol Assess (Full Rep); 2016 Oct; (224):1-826. PubMed ID: 30307735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.
    Lin PY; Su KP
    J Clin Psychiatry; 2007 Jul; 68(7):1056-61. PubMed ID: 17685742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.
    Saunders EF; Reider A; Singh G; Gelenberg AJ; Rapoport SI
    Bipolar Disord; 2015 Nov; 17(7):729-42. PubMed ID: 26424416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyunsaturated Fatty Acids: What is Their Role in Treatment of Psychiatric Disorders?
    Bozzatello P; Rocca P; Mantelli E; Bellino S
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of omega-3 fatty acids in the treatment of bipolar disorders: the current situation].
    Sempels C; Sienaert P
    Tijdschr Psychiatr; 2007; 49(9):639-47. PubMed ID: 17853373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003177. PubMed ID: 30521670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: Results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone.
    Robinson DG; Gallego JA; John M; Hanna LA; Zhang JP; Birnbaum ML; Greenberg J; Naraine M; Peters BD; McNamara RK; Malhotra AK; Szeszko PR
    Schizophr Res; 2019 Feb; 204():295-303. PubMed ID: 30241990
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.